December PCMG Blog Questions on JUPITER

• Do you normally obtain hs-CRP levels on your asymptomatic patients with normal LDL-cholesterol levels?
  
• Do you plan to switch any of your patients from their current statin therapy to rosuvastatin? If so, why?
  
• What other cardiovascular inflammatory markers are you currently screening for in your intermediate and high risk patient populations?
  
• How are the pharmaceutical representatives in your area for Merck and Pfizer handling the news about JUPITER?
  
• Are any of your patients coming to you and specifically asking you, as their physician, to place them on Crestor, based upon the results of JUPITER?